Sort
15,842 grants matching “pancreatic cancer”
Regulation of tumor suppression by alpha-ketoglutarate
$473,121Lydia Finley · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
$473,100Walter Gwang-Up Park · Stanford University · U01 · FY2020 · DK
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$473,084David G Denardo · Washington University · R01 · FY2025 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$473,069Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2023 · CA
TBEL Project 2
$472,982Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
$472,960Mohammed Noor Tantawy · Vanderbilt University Medical Center · R21 · FY2021 · CA
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
$472,957Richard Lee Nuccitelli · Bioelectromed Corporation · R43 · FY2010 · CA
Targeting Epigenomic Regulators at the Replication Fork in PDAC
$472,850Gwen Lomberk · Medical College Of Wisconsin · R01 · FY2021 · CA
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$472,823Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
Molecular Epidemiology of Pancreatic Cancer
$472,715Paige M. Bracci · University Of California, San Francisco · R01 · FY2010 · CA
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
$472,698Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$472,669Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2015 · CA
Combination Therapy for Pancreatic Cancer
$472,623Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Combination Therapy for Pancreatic Cancer
$472,623Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
MEASUREMENT ERRORS IN CANCER EPIDEMIOLOGY
$472,574Brigham And Women'S Hospital · R01 · FY2001 · CA
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
$472,491Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Structure and Functional Consequences of Serine vs. Threonine Mucin-Type O-linked Glycosylation
$472,388Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Gut pathogen virulence and its therapeutic modulation during surgical injury
$472,361John C. Alverdy · University Of Chicago · R01 · FY2024 · GM
Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy
$472,355Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy
$472,355Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
Core 3: Mouse Models Core (MM Core)
$472,258Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$472,215Lily Yang · Emory University · R01 · FY2025 · CA
Breast and Other Carcinoma Clinical Trials Using Immunotherapies
$472,182Margaret Gatti-Mays · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cancer Immunotherapy Clinical Trials
$472,182Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
The function of the PRMT5 methylosome in MTAP deleted cancers
$472,119William R Sellers · Broad Institute, Inc. · R01 · FY2025 · CA